SciELO - Scientific Electronic Library Online

 
vol.134 número7Actualización en el diagnóstico y terapéutica en hipertensión pulmonar arterialCalidad metodológica de un artículo de tratamiento de cáncer gástrico adoptado como protocolo por algunos hospitales chilenos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

MASSARDO V, Teresa et al. Role of 18Fluorine-deoxyglucose (FDG) positron emission tomography in the management of lymphomas. Rev. méd. Chile [online]. 2006, vol.134, n.7, pp. 910-919. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872006000700016.

Positron emission tomography (PET) with fluorine-18 labeled deoxyglucose (FDG) is useful in the management of lymphomas. In this review, some general concepts of this metabolic test are defined. It has an excellent diagnostic yield in Hodgkin disease as well as in most non Hodgkin lymphomas. Staging, restaging residual mass evaluation and the control of therapy are the main indications for FDG-PET. Images with FDG have a high diagnostic and prognostic value, that is superior to anatomical images and conventional staging techniques. They are also helpful for the assessment of tumor activity in abnormal lymph nodes or large masses that have been treated and reduce their size slowly or show an incomplete resolution. Currently, the resolution of dedicated PET equipments is 6 mm and bigger lesions can easily be detected. The main differences and advantages of FDG versus gallium-67 in lymphoma are also discussed, as well as the initial local experience with the technique in lymphoma patients

Palabras clave : Fluorine-18-fluorodeoxyglucose; Hodgkin disease; Lymphoma, non-Hodgkin; Positron-emission tomography.

        · texto en Español     · pdf en Español